Notch Signaling in Inflammation-Induced Preterm Labor

Area of Science:

• Reproductive Immunology
• Developmental Biology
• Molecular Signaling

Background:

• Notch signaling is crucial for innate immunity and placental function during pregnancy.
• Preterm labor involves complex immune and cellular processes.
• Understanding molecular pathways like Notch signaling is key to addressing preterm birth.

Purpose of the Study:

• To investigate the role of Notch signaling in the pathogenesis of preterm labor.
• To assess the impact of Notch pathway activation on immune responses and angiogenesis in the context of preterm labor.
• To evaluate the therapeutic potential of inhibiting Notch signaling to prevent preterm delivery.

Main Methods:

• Induction of preterm labor in a mouse model using intrauterine injections of peptidoglycan (PGN) and polyinosinic:cytidylic acid (poly(I:C)).
• Assessment of Notch pathway components (receptors, ligands, transcription factors) and immune mediators in uterine and placental tissues.
• Ex vivo and in vivo experiments using a Gamma secretase inhibitor (GSI) to block Notch receptor processing.
• Evaluation of cytokine and chemokine profiles, angiogenesis factors, and fetal survival rates.

Main Results:

• Notch signaling components (Notch1, Notch2, Notch4, DLL-1, Hes1) were upregulated during PGN+poly(I:C)-induced preterm labor.
• Gamma secretase inhibitor (GSI) treatment reduced pro-inflammatory cytokine and chemokine secretion.
• Angiogenesis factors (Jagged 1/2, DLL-4, VEGF) were decreased during induced preterm labor.
• In vivo GSI treatment significantly reduced preterm delivery rates and improved fetal survival.

Conclusions:

• Notch signaling activation is implicated in the inflammatory processes driving PGN+poly(I:C)-induced preterm labor.
• Inhibition of Notch signaling ameliorates inflammation and enhances fetal survival in a preterm labor model.
• Targeting the Notch pathway presents a potential therapeutic strategy for preventing preterm birth.